Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "f hoffmann la roche ltd"

BIOCAD: Sri-lankanisches Gericht weist Klage von F. Hoffmann-La Roche ab, den Vertrieb von Trastuzumab und Bevacizumab aus BIOCAD-Herstellung zu verbieten
Swiss Biotech

ROCHE : F. Hoffmann-La Roche Announces Half Year Results 2016

Release date- 21072016 - F. Hoffmann-La Roche Ltd. (hereafter 'Roche') [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today its half year results 2016 (January 1 - June 30, 2016). Roche owns 59.89% of Chugai's outstanding shares ... 4 Traders, 6 days ago
[x]  

9 images for f hoffmann la roche ltd

Treasury Today, 1 week ago
Treasury Today, 1 week ago
Medagadget.com, 3 months ago
Swiss Biotech, 3 weeks ago
Medagadget.com, 4 months ago
Professional Security, 5 months ago
Livemint.com, 6 months ago
Business Standard India, 6 months ago
Medagadget.com, 6 months ago
MyNewsDesk

Pigmented Villonodular Synovitis Pipeline Report 2016 - Therapeutic Review of F. Hoffmann-La Roche, Five Prime Therapeutics, Novartis & Plexxikon - Research and Markets

DUBLIN--(BUSINESS WIRE)-- Research and Markets has announced the addition of the "Pigmented Villonodular Synovitis - Pipeline Review, H1 2016" report to their offering. This report provides comprehensive information on the therapeutic ...
 Benzinga.com1 month ago Pemphigus Vulgaris - Pipeline Review, H1 2016 Featuring Almirall, Biogen, F. Hoffmann-La Roche, HanAll Biopharma, Immunomedics, Novartis & Principia Biopharma - Research and Markets  4 Traders1 month ago Market Review on Tumor Necrosis Factor Receptor Superfamily Member 5 - Pipeline Review, H1 2016  MyNewsDesk18 hours ago Market Overview on Corticosteroid 11-Beta-Dehydrogenase Isozyme 1 - Pipeline Review, H1 2016  MyNewsDesk19 hours ago
[x]  

Global Solid Tumors Drugs Market

(Before It's News) Global solid tumors drugs market: F. Hoffmann-La Roche, Novartis, Celgene, Johnson & Johnson, Pfizer, and BMS. Other Prominent Vendors in the market are: AbbVie, AbGenomics, ADC Therapeutics, Advantagene, Agensys, Almac ...
 Before It's News1 week ago Global Epilepsy Drugs Market 2016-2020  MarketResearch.com1 week ago Global Solid Tumors Drugs Market 2016-2020  MarketResearch.com2 weeks ago ​Global Solid Tumors Drugs Market  MyNewsDesk1 week ago

IDFC Bank informs about allotment of shares under ESOS

Industry: Banks & Finance Company IDFC Bank Ltd IDFC Bank has informed that the Allotment and Share Transfer Committee of the Bank met on July 05, 2016 and allotted 51,387 fully paid up equity shares of Rs 10 each to the employees in terms of ...
 Finalaya.com3 weeks ago

Asian Granito gains on plan to launch two new products

Industry: Construction Material Company Asian Granito India Ltd Asian Granito India is currently trading at Rs 194.30, up by 1.25 points or 0.65% from its previous closing of Rs. 193.05 on the BSE. The scrip opened at Rs. 193.05 and has ...
 Finalaya.com3 weeks ago

HCC-MMS JV bags contract worth Rs 2523 crore

Industry: Construction Material Company Hindustan Construction Company Ltd Hindustan Construction Company (HCC), acting as a lead partner in the joint venture with MMS of Russia, has been awarded Rs 2523 crore contract by the Mumbai Metro ...
 Finalaya.com3 weeks ago

Hero MotoCorp inks three years wage agreement with Gurgaon workers

Industry: Automobile Company Hero MotoCorp Ltd Hero MotoCorp (HMCL), the world's largest two-wheeler manufacturer, has signed a three years salary settlement agreement with its permanent workers at Gurgaon Plant, entailing a hike of Rs 12500 ...
 Finalaya.com3 weeks ago
MyNewsDesk

Anemia and Vitamin Test Market : Global Industry Analysis and Forecast 2016 - 2026

Persistence Market Research Pvt. Ltd is released new forthcoming report on title " ". Anemia is a clinical condition where the human body does not have enough Red Blood Cells (RBC) or Haemoglobin or both which are paramount important to ...
 Press Release Ping3 weeks ago Infectious Immunology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 Published By MarketResearchReports.biz  MyNewsDesk13 hours ago Immuno-Oncology Market : Global Industry Analysis and Forecast 2016 - 2026  Digital Journal6 days ago Immunochemistry Analyzer Market Trends and Competitive Landscape Outlook to 2025  MyNewsDesk1 week ago

Global Analgesics Market 2016-2020

TechNavio - Infiniti Research Ltd. About the Analgesics Market Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief.
 MarketResearch.com2 weeks ago

Eleven Biotherapeutics Announces Effectiveness of Investigational New Drug Application for EBI-031

Eleven Biotherapeutics announces IND effectiveness for EBI-031 triggering $22.5 million milestone payment from Roche Eleven Biotherapeutics, Inc.( NASDAQ: EBIO ), a biopharmaceutical company discovering and developing protein therapeutics to treat ...
 BioSpace3 weeks ago Eleven Biotherapeutics announces license agreement with Roche  PredictWallStreet1 month ago Eleven Biotherapeutics: What Went Wrong, What Went Right, And How You Can Spot Similar Opportunities In The Future  Seeking Alpha2 weeks ago #Biopharma News: Eleven Biotherapeutics (NASDAQ: $EBIO) Announces Effectiveness of Investigational New Drug Application for EBI-031  InvestorIdeas.com2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - f hoffmann la roche ltd
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less